Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Vertex Pharmaceuticals Incorporated - SWOT, Strategy and Corporate Finance Report - New Market Research Report


Print article Print article
2013-12-04 12:09:05 - New Business research report from MarketLine is now available from Fast Market Research

Vertex Pharmaceuticals Incorporated - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
* An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Vertex Pharmaceuticals Incorporated
* Intelligence on Vertex Pharmaceuticals Incorporatednv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/737904_vertex_pharmaceuticals_incorporated_s ..

Highlights:

Vertex Pharmaceuticals Incorporated (Vertex or 'the company') is a commercial-stage biotechnology company engaged in the discovery, development and commercialization of small molecule drugs for the treatment of major diseases such as viral infections, cystic fibrosis, inflammation, autoimmune disorders and cancer. The company operates in the US. It is headquartered in Cambridge, Massachusetts and employed 2,200 people as of December 31, 2012. The company recorded revenues of $1,527 million during the financial year ended December 2012 (FY2012), an increase of 8.3% over FY2011. The operating profit of the company was $2.3 million in FY2012, a decrease of 98% over FY2011. The net loss was $107 million in FY2012, as compared to a net profit of $29.6 million in FY2011.

Reasons to Purchase:

* Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Vertex Pharmaceuticals Incorporated's business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Vertex Pharmaceuticals Incorporated: Company Overview
Vertex Pharmaceuticals Incorporated: Overview and Key Facts
Vertex Pharmaceuticals Incorporated: Overview
Vertex Pharmaceuticals Incorporated: Key Facts
Vertex Pharmaceuticals Incorporated: Key Employees
Vertex Pharmaceuticals Incorporated: Key Employee Biographies
Vertex Pharmaceuticals Incorporated: Major Products and Services
Vertex Pharmaceuticals Incorporated: Company History
Vertex Pharmaceuticals Incorporated: Management Statement
Vertex Pharmaceuticals Incorporated: Key Competitors
Vertex Pharmaceuticals Incorporated: Company Analysis
Vertex Pharmaceuticals Incorporated: Business Description
Vertex Pharmaceuticals Incorporated: SWOT Analysis
Vertex Pharmaceuticals Incorporated: SWOT Overview
Vertex Pharmaceuticals Incorporated: Strengths
Vertex Pharmaceuticals Incorporated: Weaknesses
Vertex Pharmaceuticals Incorporated: Opportunities
Vertex Pharmaceuticals Incorporated: Threats
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity
Vertex Pharmaceuticals Incorporated: Financial Deals Overview
Vertex Pharmaceuticals Incorporated: Targets and Partners
Vertex Pharmaceuticals Incorporated: Top Deals 2009 - 2013YTD*
Vertex Pharmaceuticals Incorporated: Advisors
Vertex Pharmaceuticals Incorporated: Top Legal Advisors
Vertex Pharmaceuticals Incorporated: Top Financial Advisors
Vertex Pharmaceuticals Incorporated: Capital Raising
Vertex Pharmaceuticals Incorporated: Partnership
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 4: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 7: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 8: Vertex Pharmaceuticals Incorporated: Top Deals 2009 - 2013YTD*
Table 9: Vertex Pharmaceuticals Incorporated: Legal Advisor Ranking by Value (US$m)
Table 10: Vertex Pharmaceuticals Incorporated: Financial Advisor Ranking by Value (US$m)
Table 11: Vertex Pharmaceuticals Incorporated: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 12: Vertex Pharmaceuticals Incorporated: Capital Raising by Deal Type (2009 - YTD*2013)
Table 13: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2009 - YTD*2013)

List of Figures

Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 3: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: Vertex Pharmaceuticals Incorporated: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 5: Vertex Pharmaceuticals Incorporated: Capital Raising by Deal Type (2009 - YTD*2013)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=737904&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com